NVHR Strategic Plan

Share this

2015-2017 Strategic Plan

The National Viral Hepatitis Roundtable is a broad coalition working to fight, and ultimately end, the hepatitis B and hepatitis C epidemics. We seek an aggressive response from policymakers, public health officials, medical and health care providers, the media, and the general public through our advocacy, education, and technical assistance. 

NVHR believes an end to the hepatitis B and C epidemics is within our reach and can be achieved through addressing stigma and health disparities, removing barriers to prevention, care and treatment, and ensuring respect and compassion for all affected communities. 




Goal #1: PREVENT

Individuals at high risk for hepatitis B and/or hepatitis C have tools and information necessary to prevent infection.


  • Advocate for appropriate drug policy legislation and strategies as means to prevent new hepatitis B and hepatitis C infections, including lifting the ban on the use of federal funds for syringe services programs, expanding access to opioid substitution therapy, and supporting efforts to address the opioid/heroin misuse crisis.
  • Advocate for increased federal funding for adult hepatitis B immunizations. 
  • Provide the hepatitis B and hepatitis C perspective in the development and execution of broad sexual health strategies.
  • Develop and implement strategies to eliminate hepatitis B perinatal transmission in the United States.


Goal #2: TEST

Everyone at risk for hepatitis B and/or hepatitis C infection is tested, and if positive, linked to care.


  • Provide technical assistance, education, and sharing of best practices, about effective hepatitis C testing and linkage to care strategies through NVHR’s Baby Boomer Hepatitis C Screening Program.
  • Lead advocacy efforts to implement the United States Preventive Services Task Force’s hepatitis B and hepatitis C testing recommendations, with a focus on Medicare, Medicaid, community health centers, and private insurance.
  • Advocate for increased federal funding for hepatitis B and C testing and linkage to care programs at the Division of Viral Hepatitis, Centers for Disease Control and Prevention, and other federal agencies.
  • Support efforts to increase hepatitis B testing at the state and local levels through coalition building and sharing of best practices.


Goal #3: CURE

All people with hepatitis C have access to curative treatment.


  • Lead coalition efforts to end the hepatitis C treatment access crisis, with a focus on encouraging stakeholders (pharmaceutical industry, private and public payers, government, medical experts, community) to reach short and long-term solutions that will reduce barriers to hepatitis C treatment access and eliminate discriminatory restrictions. 
  • Support advocacy efforts at the state level to address treatment restrictions in state Medicaid programs.
  • Provide the patient perspective in public forums and to the media.



Organizations and individuals impacted by hepatitis B and C have tools to be effective advocates at the local, state, and national levels.


  • Write and disseminate Action Alerts on key hepatitis B and C policy issues, with clear instructions and tips on communication with elected officials.
  • Provide training to member organizations on effective advocacy through webinars, conference calls, social media and written materials to increase their capacity to mobilize their constituencies. 
  • Organize and facilitate regular federal public policy update calls to provide information about the broad range of legislative and administrative issues impacting hepatitis B and C.